🧬
01
Introduction and original source content
BIOHACKING 360 LABS — LIPID METABOLISM
AOD-9604 PEPTIDE
AOD-9604 is a synthetic peptide fragment derived from human growth hormone (hGH). It was developed to investigate effects on lipid metabolism and fat mobilization. Unlike full-length growth hormone, this fragment was designed to target pathways associated with lipolysis without reproducing the anabolic and growth-promoting effects attributed to intact hGH.
Its experimental investigation has attracted interest in weight-management research, regenerative medicine, and metabolic research.
⚙️
02
Mechanism of Action
MECHANISM OF ACTION
The source document describes the principal actions of AOD-9604 as stimulation of lipolysis and inhibition of lipogenesis. It reports that experimental studies have investigated the peptide's capacity to promote the breakdown of stored lipids and the utilization of fatty acids as an energy substrate.
The document also describes activity involving receptors associated with adipose-tissue metabolism, without major effects on appetite or marked changes in blood glucose or insulin concentrations. These statements should be interpreted in the context of the studies from which they originated, not as established clinical effects.
🔬
03
Fat Mobilization and Utilization
FAT MOBILIZATION AND UTILIZATION
The compound has been investigated for its proposed ability to influence signaling in adipocytes and facilitate the release and utilization of stored body fat.
The source identifies particular interest in anatomical regions where adipose tissue commonly accumulates, including:
✓
Lower abdomen. * Waist. * Hips. * Back.
The proposed objective is to investigate whether stored lipids can be mobilized and subsequently used as an energy source.
BIOHACKING 360 LABS 01 / 03
🧬
04
Introduction and original source content
BIOHACKING 360 LABS — RESEARCH / STORAGE
AOD-9604
🌱
05
Applications in Regenerative Medicine
APPLICATIONS IN REGENERATIVE MEDICINE
In addition to its investigation in lipid metabolism, the source document discusses AOD-9604 as an adjunct in research-oriented protocols concerned with physical recovery and musculoskeletal well-being.
Certain experimental approaches have considered combining it with other peptides, including BPC-157, to investigate possible complementary effects on tissue repair and regeneration. These uses should not be interpreted as clinically established therapeutic indications.
🔥
06
Metabolic Safety
METABOLIC SAFETY
The source document describes a potentially favorable metabolic profile for AOD-9604.
It reports that the fragment does not exhibit the growth-promoting properties associated with full-length growth hormone and that significant changes in glucose or insulin concentrations have generally not been observed in the studies discussed.
These observations do not establish comprehensive safety in humans and require interpretation according to the populations, doses, and designs of the underlying studies.
⏱️
07
Role of the Fasting State
ROLE OF THE FASTING STATE
The source document describes experimental protocols in which fasting conditions have been proposed as a means of influencing fat mobilization.
It also discusses the physiological relationship between lower circulating insulin concentrations, lipolysis, and fatty-acid utilization.
These descriptions are presented as research context rather than instructions for administering the compound.
❄️
08
Reconstitution and Storage
RECONSTITUTION AND STORAGE
The source document states that, following reconstitution, the vial should be kept under refrigeration to help preserve peptide stability and minimize degradation.
Appropriate storage is described as important for maintaining product integrity. Specific stability limits and validated storage conditions are not established by this document alone.
🔬
09
Administration
ADMINISTRATION
The source document describes subcutaneous administration of AOD-9604 and identifies abdominal subcutaneous adipose tissue as a site discussed in research-oriented protocols.
This information is retained as part of the original technical record. It is not a recommendation for human administration.
BIOHACKING 360 LABS 02 / 03
🧬
10
Introduction and original source content
BIOHACKING 360 LABS — PROTOCOLS / REFERENCES
AOD-9604
📋
11
Protocols Described in Research
PROTOCOLS DESCRIBED IN RESEARCH
The source document describes experimental and clinical research protocols involving daily administration, with the stated objective of investigating body-fat mobilization and utilization.
It further reports proposals involving morning administration during fasting, based on the hypothesis that lower postprandial insulin exposure could influence lipid mobilization.
The source also discusses alternating study periods and rest intervals to assess metabolic responses and investigate potential tolerance.
These descriptions reproduce the source's research context and do not constitute a validated dosing or treatment regimen.
✨
12
Conclusions
CONCLUSIONS
AOD-9604 has been investigated as a growth-hormone-derived peptide fragment in studies concerning the regulation of lipid metabolism.
Its molecular design provides a basis for investigating mechanisms associated with lipolysis while seeking to avoid some systemic actions of full-length growth hormone.
The source document describes potentially favorable metabolic findings and interest in weight-management research, regenerative medicine, and energy metabolism. These statements should not be construed as proof of clinical efficacy or safety.
📚
13
Bibliographic References
BIBLIOGRAPHIC REFERENCES
✓
Ng FM, et al. Human obesity and the development of AOD9604. Obesity Research.
✓
Heffernan M, et al. Anti-obesity effects of the growth hormone fragment AOD9604. International Journal of Obesity.
✓
Metabolic effects of AOD9604 in experimental and clinical studies. Endocrine Reviews.
✓
Journal of Endocrinology and Metabolism.
✓
International Journal of Obesity.
The entries above are transcribed from the source document; their bibliographic completeness and accuracy have not been independently verified.
BIOHACKING 360 LABS 03 / 03